To evaluate the functions of flavohemoglobin and whose growth in vitro and in infected animals is con-GSNO reductase in C. neoformans, we disrupted the trolled by NO bioactivity [7-11]. We show that both FHB1 and GNO1 genes individually and in combination, flavohemoglobin denitrosylase and GSNO reductase and the resulting mutant strains were evaluated for NO contribute to C. neoformans pathogenesis. FHB1 and and GSNO resistance (Figure 1) . The FHB1 and GNO1 GNO1 mutations abolished NO-and GSNO-consuming genes were not essential for vegetative growth; howactivity, respectively. Growth of fhb1 mutant cells was ever, when NO consumption was assayed in wild-type, inhibited by nitrosative challenge, whereas that of fhb1 mutant, fhb1 ϩ FHB1 reconstituted, and gno1 mugno1 mutants was not. fhb1 mutants showed attenutant strains, no NO consumption was detected in fhb1 ated virulence in a murine model, and virulence was mutant cells in contrast to wild-type cells, which exhibrestored in iNOS Ϫ/Ϫ animals. Survival of the fhb1 muited robust NO consumption. Reintroduction of the tant was also reduced in activated macrophages and FHB1 gene at its endogenous locus restored the ability restored to wild-type by inhibition of NOS activity.
18], and there is some evidence of the importance of NO in cryptococcal infection [19] , yet C. neoformans In an independent screen, a library of random insertional mutants was tested for NO hypersensitivity. The FHB1 can replicate within the hostile intracellular environment of the macrophage as a facultative intracellular pathogene was independently identified twice in this screen, validating its importance in counteracting the toxic efgen [7, 9, 10] . This paradox underscores our limited understanding of when and how C. neoformans evades fects of nitrosative challenge. Taken together, these findings demonstrate that flavohemoglobin protects fungal the nonspecific host immune response. Given our in vitro findings, we hypothesized that flavocells from nitrosative challenge but does not metabolize GSNO.
hemoglobin would play a role in protecting C. neoformans from NO during infection. We assessed viruIn contrast to the situation in S. cerevisiae, intracellular GSNO does not accumulate upon exposure to extracellence by using a murine inhalation model in which infection begins in the lung, spreads hematogenously, lular GSNO. Rather, C. neoformans evidently converts GSNO to NO, which is then detoxified by flavohemogand leads to lethal meningoencephalitis, thus mimicking many aspects of human infection. A/Jcr and C57BL/6 lobin ( Figure 2D ). Such "SNO lyase" activity has been previously observed in E. coli [5, 15] , and a similar mechmice were infected with wild-type, fhb1 mutant, and fhb1 ϩ FHB1 reconstituted strains, and in six indepenanism has been established for protection by catalase against superoxide, which is reduced by cellular constitdent experiments the fhb1 mutant was less virulent than the wild-type. For example, in an experiment using an uents to H 2 O 2 . The relative importance of these pathways compared to flavohemoglobin denitrosylation may be inoculum size of 1 ϫ 10 5 cells, the mean survival of A/Jcr mice infected with the fhb1 mutant strain was 26.4 days, different in other organisms; unlike the C. neoformans enzyme, GSNO reductase protects S. cerevisiae from compared to 21.6 days for the wild-type (p ϭ 0.0006 fhb1 versus wild-type) ( Figure 3A ). Virulence was restored to nitrosative stress [4] , and mice, which use S-nitrosylation for signaling, do not have flavohemoglobin but the wild-type level in the fhb1 ϩ FHB1 reconstituted strain, and the mean survival was 22.1 days (p ϭ 0.22 rather utilize GSNO reductase to control the levels of S-nitrosylated proteins [4, 16] . fhb1 ϩ FHB1 versus wild-type), demonstrating that the virulence defect is attributable solely to the fhb1 mu-NO is produced by inducible or constitutive forms of NO synthase and is an important signaling and effector tation. To test whether the virulence defect observed in muwild-type versus fhb1) ( Figure 3B ). These findings demonstrate that flavohemoglobin contributes to fungal virutant strains lacking flavohemoglobin was solely due to hypersensitivity to nitrosative challenge, we infected lence in a second mouse background. Moreover, without the nitrosative components of immunity, the fhb1 mice lacking both copies of the NOS2 gene encoding the inducible form of NO synthase (iNOS) with wild-type mutant, compared to the wild-type, displayed no virulence defect in the in vivo model, reinforcing the hypoand the fhb1 mutant strain. Because the immune cells in these mice are unable to express iNOS in response thesis that flavohemoglobin detoxifies NO generated by host iNOS during infection. to pathogens, they do not generate reactive nitrogen species typical of murine infection models. Although
In contrast to the attenuated virulence of the fhb1 mutant strain, the gno1 mutant was as virulent as the there was a clear virulence defect for the fhb1 mutant (mean survival ϭ 31.7 days) compared to wild-type H99 wild-type ( Figure 3C ), in accord with our in vitro findings that gno1 mutant cells proliferated normally in the pres-(mean survival ϭ 26.9 days) in the wild-type C57BL/6 background expressing iNOS (p ϭ 0.03 wild-type versus ence of NO. However, virulence of an fhb1 gno1 double mutant lacking both enzymes was more attenuated than fhb1), iNOS Ϫ/Ϫ animals from the same mouse background infected with wild-type and fhb1 mutant had either the fhb1 or the gno1 single mutant (p ϭ 0.04 fhb1 gno1 versus fhb1) (p Ͻ 0.001 fhb1 gno1 versus gno1) mean survival times of 20 and 21 days, respectively, a difference that was not statistically significant (p ϭ 0.27 ( Figure 3C ). Thus, in the absence of flavohemoglobin, nitrosants and oxidants, but the additive influence of the fhb1 and sod1 mutations suggests independent antifungal effects. Studies of enzymes that metabolize per-
